New Psychotherapies for Mood and Anxiety Disorders: Necessary Innovation or Waste of Resources?/Reply

[...] the field should focus on the real problems that limit the contribution of therapies to the reduction of disease burden, including the large number of patients who do not respond to any treatment, the patients who still have considerable residual symptoms after successful treatments, and patients who relapse. [...] some of the innovations in psychotherapy development over the past 20 years have been along these lines (for example, relapse prevention strategies or well-being therapy for residual symptoms).